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Objective: To evaluate if quantitative joint space width (JSW) measurements from radiographs correlate
with 4-year Knee injury and Osteoarthritis Outcome Scores (KOOS) and clinical performance measures.
Method: The study group consisted of 942 patients with symptomatic knee osteoarthritis (OA). 4-year
outcomes for six measures (KOOS Pain, Symptom, Quality of Life, and Function scores, 20-m walk
pace, and chair stand time) were used to create six multiple linear regression models. Primary predictors
were baseline minimum JSW and 4-year change in JSW measured from ﬁxed ﬂexion radiographs. Age,
gender, body mass index (BMI), race, knee alignment, and baseline measures of the outcomes of interest
were covariates.
Results: Lower baseline minimum JSW and a greater decrease in 4-year JSW signiﬁcantly correlated with
worse 4-year KOOS Pain, Symptom, and Quality of Life. With all other factors constant, a 4.1, 4.8, and
5.6 mm lower baseline JSW correlated with a clinically signiﬁcant eight-point drop in 4-year KOOS Pain,
Symptom, and Quality of Life scores respectively. Additionally, a 3.5, 3.1, and 4.0 mm loss of JSW over 4
years correlated with a clinically signiﬁcant eight-point drop in 4-year KOOS Pain, Symptom, and Quality
of Life scores respectively.
Conclusions: Our results indicate quantitative radiographic JSW measurements correlate with 4-year
clinical outcomes. Since patients with narrower JSW at the onset of study had lower KOOS scores at 4
years even after controlling for 4-year change in JSW and baseline KOOS scores, clinical outcomes in knee
OA may be predetermined once the disease process begins. These ﬁndings suggest early treatment with
disease modifying therapies may be necessary to inﬂuence outcomes.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is one of the most common causes of
disability in the United States and presents a large burden on in-
dividuals and the healthcare system. The knee is one of the most
common joints affected by OA with an estimated prevalence in
adults over 45 of 19.2% and 27.8% in the Framingham Study and
Johnson County Osteoarthritis Project, respectively1. The preva-
lence is expected to grow in the coming years as a result of an aging: S.R. Oak, Cleveland Clinic
leveland, OH 44195, USA.
ada@ccf.org (A. Ghodadra),
. Miniaci), jonesm7@ccf.org
s Research Society International. Ppopulation. Furthermore, the lifetime risk of having symptomatic
knee OA is estimated to be 45% for the general population and 61%
among obese individuals2. In terms of healthcare utilization, pa-
tients with knee OA have been shown to have signiﬁcantly more
doctor’s visits and hospitalizations than patients without knee OA3.
In 2009, one study estimated over 600,000 hospital discharges in
the US as a result of knee OA costing $28.5 billion4.
The pathogenesis of knee OA involves articular cartilage
degradation, inﬂammation of synovial tissues, and changes in
subchondral bone5. As a standard measure of anatomical disease
progression, joint space width (JSW) is the distance measured be-
tween the femoral condyle and tibial plateau on radiographs ob-
tained in a standardized fashion. Articular cartilage loss is indirectly
inferred based on loss of JSW and referred to as joint space nar-
rowing (JSN)6. Magnetic resonance imaging (MRI) has proved to be
a very sensitive technique to evaluate the status of most kneeublished by Elsevier Ltd. All rights reserved.
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However, despite the advances in MRI and quantitative image
analysis techniques, radiographic JSN is currently the biomarker
accepted by the United States Food and Drug Administration (FDA)
and European Agency for the Evaluation of Medicinal Products
(EMEA) as an end point in clinical trials for measurement of OA
progression6.
JSNmeasurements are appropriate to estimate structural disease
progression, but they do not directly evaluate the impact of knee OA
on patients’ lives. The Knee injury and Osteoarthritis Outcome Score
(KOOS) is a validated and reliable patient-reported outcome mea-
sure evaluating pain, symptoms, function, and quality of life7. Other
objective performance tests, including 20-m walk pace and time to
perform ﬁve chair stands, can also be used to measure patients’
abilities8. These clinical measurements are suitable to evaluate the
progression of knee OA as experienced by the patient.
Although a relationship between radiographic and clinical knee
OA progression would be anticipated, evidence to date has not
established a strong correlation. A systematic search of the literature
by Bedson and Croft in 2008 concluded that radiographic changes in
knee OA were an imprecise marker of knee pain9. They concluded
the discordance was caused by variations in X-ray views, X-ray
grading, pain deﬁnition, and study population. A systematic review
conducted in 2011 supported the discordance and found only 10% of
reviewed studies associated radiographic and clinical OA features10.
The Osteoarthritis Initiative (OAI) is a longitudinal, multicenter,
prospective, observational cohort study of knee OA. A publically
available database has been established containing yearly clinical
assessments, biospecimens, MRI, X-ray, and outcome data from pa-
tients with symptomatic OA or at elevated risk of OA11. Over 4,700
patients ages 45e79were enrolled between February 2004 andMay
2006. This databaseprovides avaluable opportunity to followa large,
nationwide patient group. In this study, we evaluate the association
of radiographic disease state and clinical outcome measures in a
cohortofOAIpatients.Wehypothesize that JSNover4yearswouldbe
associated with worsening clinical outcomes after adjusting for de-
mographic factors, baseline JSW, and baseline clinical scores.
Methods
Study population
Dataused in thepreparationof this articlewere obtained fromthe
OAI database, which is available for public access at http://www.oai.
ucsf.edu/. Speciﬁc datasets used were AllClinical 0.2.2 and 6.2.1 and
kXR quantJSW 0.5 and 6.2. Patients for the current study were
derived from the progression subcohort. Inclusion into this sub-
cohort was based on having both of following criteria in at least one
knee at enrollment: “pain, aching, or stiffness in or around the knee
on most days” for at least 1 month in the past 12 and deﬁnite tibio-
femoral osteophytes (Osteoarthritis Research Society International
atlas grades 1e3 or Kellgren and Lawrence grade 2) on the ﬁxed
ﬂexionradiograph.With thesecriteria,we identiﬁed1,278patientsof
which 942 had complete data for all variables of interest and were
included in our analyses. The patient’s right knee was chosen as the
unit of analysis to avoid duplication of nonbilateral data.
Predictor variables
Minimum and ﬁxed location JSW measurements for the medial
compartment and ﬁxed location JSW measurements for the lateral
compartment from radiographs that were obtained under the stan-
dardized ﬁxed ﬂexion acquisition protocol (http://oai.epi-ucsf.org/
datarelease/operationsManuals/RadiographicManual.pdf) were colle
cted from the OAI database. Minimum quantitative JSW and ﬁxedlocation JSWweremeasured for theOAI using an automated software
method12,13.MinimumJSWfromtheOAIwasdeﬁnedas theminimum
distance between the femur and tibia in the medial tibiofemoral
compartment. In ﬁxed location JSW measurements, the distance be-
tween the femur and tibia was measured at ﬁxed intervals in the
medial and lateral compartments. In the current study, the variable
quantitative minimum JSW represented the lowest ﬁxed interval
measurement made from the medial or lateral compartment. The
predictor variables of primary interest were baseline quantitative
minimum JSWand 4-year change inminimum JSW (JSN). The 4-year
JSNwascalculatedbysubtracting thebaselineminimumJSWfromthe
minimum JSWat 4 years after enrollment. This analysis was repeated
for the most responsive JSW at x ¼ 0.275. To control for potential
confounding, several covariates were included in the analyses based
on previous literature14,15. These included age, gender, body mass
index (BMI), race, knee alignment, and baseline measures of the
4-year outcome of interest. OAI variable names for the predictor var-
iables used were V00AGE, P02SEX, P01BMI, P02RACE, V00rkdefcv,
V00RKALNMT, V00KOOSKPR, V00KOOSYMR, V00KOOSQOL, V00KOO
SFSR, V00CSTIME1, and V0020MPACE.
Outcome measures
Six clinical outcome measures were selected from the OAI
database and were categorized as either patient-reported outcomes
or performance measures. The patient-reported outcomes were
KOOS Pain, Symptom, Quality of Life, and Function, Sports, and
Recreation scores measured 4 years after enrollment. KOOS scores
range from 0 to 100. A score of 0 represents extreme knee problems,
100 represents no knee problems, and a score change of eight rep-
resents the minimum perceptible clinical improvement7. The per-
formance measures were 20-m walk pace and time to perform ﬁve
chair stands measured 4 years after enrollment. OAI variable names
for the outcome variables used were V06KOOSKPR, V06KOOSYMR,
V06KOOSFSR, V06KOOSQOL, V06CSTIME1, and V0620MPACE.
Statistical analysis
To test for signiﬁcant differences between all patients and patients
included in the analysis, two-tailed two-sample student’s t tests with
equalvariancesor two-proportion z testswereperformed. Toestimate
the effect of multiple predictors on outcomes, multiple linear regres-
sion modeling was performed using the statistical software package
JMP 9 (SAS Institute, Cary, NC). Eachmodel consisted of one outcome
measure, nine predictor variables, and two interaction product terms.
The nine predictor variables consisted of four demographic variables,
two alignment variables, one baseline measure of the outcome of in-
terest, and two JSW variables. Two cross product terms to account for
potential interactionwere 4-year JSN multiplied by baseline JSW and
4-year JSNmultipliedbyalignment. Theassumptionsofnormalityand
constant variance of residuals and independence between observa-
tions were met. Effect tests using the f-ratio were used to test for
statistical signiﬁcanceof eachvariable in themodels. Ana level of 0.05
was used in evaluating signiﬁcance in Table I. An a level of 0.01 was
used to evaluate statistical signiﬁcance in the multiple linear regres-
sionmodel.A signiﬁcance level of 0.01was chosen to reduce the riskof
a Type 1 error as a result of performing six regressions.
Results
Patient characteristics
Descriptive statistics for each predictor can be found in Table I.
Hypothesis testing was performed comparing means between all
patients (n ¼ 1,278) and patients included in analysis (n ¼ 942).
Table I
Descriptive statistics for predictor variables
All patients (n ¼ 1278) Patients included in analysis with all data
points (n ¼ 942)
P-value
Mean (SD) Median
(Min, Max)
Count (%) Mean (SD) Median
(Min, Max)
Count (%)
Baseline age 61.3 (9.1) 61 (45, 79) 61.2 (9.1) 61 (45, 79) 0.65
Gender
Male 565 (44.2) 442 (46.9) 0.21
Female 713 (55.8) 500 (53.1) 0.21
Baseline BMI 30.2 (4.9) 29.7 (18.2, 48.7) 29.8 (4.7) 29.5 (18.2, 48.7) 0.11
Race
White or Caucasian 915 (71.6) 705 (74.8) 0.09
Black or African American 325 (25.4) 211 (22.4) 0.10
Asian 11 (0.9) 7 (0.7) 0.60
Other non-white 27 (2.1) 19 (2.0) 0.87
Baseline alignment
Valgus 524 (41.6) 393 (41.7) 0.96
Varus 380 (30.1) 304 (32.3) 0.27
Neither 357 (28.3) 245 (26.0) 0.23
Baseline alignment, degrees (valgus
negative)
0.47 (4.08) 0 (22, 15) 0.33 (4.04) 0 (22, 15) 0.40
Baseline KOOS pain score 73.5 (19.2) 75 (3, 100) 75.1 (18.7) 78 (6, 100) 0.04
Baseline KOOS symptoms score 77.6 (17.1) 82 (21, 100) 79.2 (16.2) 82 (21, 100) 0.03
Baseline KOOS quality of life score 51.5 (19.4) 50 (0, 100) 52.9 (18.5) 56 (0, 100) 0.09
Baseline KOOS function, sports, and
recreational activities score
53.9 (26.1) 50 (0, 100) 55.2 (25.6) 55 (0, 100) 0.32
Baseline repeated chair stands (seconds.
hundreths)
13.06 (4.79) 12.14 (4.00, 53.13) 12.83 (4.57) 12.03 (5.09, 48.57) 0.29
Baseline 20-m walk: pace (m/sec) 1.27 (0.22) 1.28 (0.24, 1.96) 1.29 (0.21) 1.29 (0.56, 1.96) 0.12
Baseline minimum JSW [mm] 3.58 (1.54) 3.8 (0.0, 7.9) 3.73 (1.46) 3.9 (0.0, 7.7) 0.02
4-year JSN [mm] 0.55 (0.94) 0.4 (5.2, 3.9) 0.54 (0.94) 0.4 (5.2, 3.9) 0.90
a level ¼ 0.05.
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predictors except baseline KOOS Pain score, baseline KOOS Symp-
tom score, and baseline minimum JSW. The difference in KOOS Pain
score and KOOS Symptom scorewas 1.6 between both groups.With
a threshold for clinical signiﬁcance at a KOOS score of 8, these
differences were not clinically signiﬁcant. The difference in baseline
minimum JSW between groups was 0.15 mm. With a threshold for
the smallest detectable difference in quantitative JSW being
0.2 mm, this difference was not clinically signiﬁcant6.
Regression modeling
Table II shows the results of predictor variables in each of the six
multiple linear regression models created. Additional informationTable II
Predictor variables and model results
Variable 4-year KOOS measures, P-values
Pain Symptom Function,
and recre
Baseline value of the 4-year outcome <.0001* <.0001* <.0001*
Baseline minimum JSW [mm] <.0001* <.0001* 0.1086
4-year JSN [mm] <.0001* <.0001* 0.0223
Baseline age 0.0208 0.0002* 0.8286
Gender 0.7298 0.6797 0.3737
Baseline BMI 0.0775 0.3986 0.4076
Racial background 0.0062* 0.0563 0.8281
Baseline alignment 0.0426 0.37 0.1293
Baseline alignment, degrees
(valgus negative)
0.9426 0.7799 0.2579
(Baseline minimum JSW) 
(4-year JSN)
0.4598 0.5705 0.3093
(Baseline alignment) 
(4-year JSN)
0.0022* 0.0817 0.7061
Model R2 0.346 0.356 0.354
* Indicates P-value <0.01 for the F-test of each variable.on parameter estimates and conﬁdence intervals for each model
can be found in Supplemental Tables 1e6. Baseline measures of the
outcome of interest were signiﬁcantly correlated with the 4-year
outcome in all six models. For example, a better baseline KOOS Pain
score signiﬁcantly correlated with a better 4-year KOOS Pain score.
Lower minimum baseline JSW and a negative 4-year JSN were
correlated with signiﬁcantly worse 4-year KOOS Pain, Symptom,
and Quality of Life scores. There were no signiﬁcant correlations
between minimum baseline JSW or 4-year JSN and 4-year KOOS
Function, Sports, and Recreation scores and performance measures.
Repetition of these analysis for JSW at x ¼ 0.275 showed similar
results (Supplemental Table 7).
Table III displays model parameter estimates and changes in the
variable needed to cause a clinically signiﬁcant eight-point decrease4-year performance measures, P-values
Sports,
ation
Quality of life 20-m walk
pace (m/sec)
Repeated chair
stands time (sec)
<.0001* <.0001* <.0001*
0.0011* 0.0174 0.9402
0.0022* 0.1986 0.7749
0.002* <.0001* <.0001*
0.9521 0.2476 0.9228
0.0879 0.0002* 0.0204
0.3495 <.0001* 0.0692
0.5085 0.7171 0.1859
0.6794 0.953 0.1998
0.3138 0.1717 0.1105
0.0877 0.9281 0.2
0.319 0.557 0.290
Table III
Variable values associated with a clinically signiﬁcant change in 4-year KOOS outcome
Variable 4-year KOOS outcome
Pain Symptom Quality of life
Parameter
estimate
(95% CI)
Change associated
with eight-point
decrease in KOOS
Parameter
estimate
(95% CI)
Change associated
with eight-point
decrease in KOOS
Parameter
estimate
(95% CI)
Change associated
with eight-point
decrease in KOOS
Baseline value of the
4-year outcome
0.49 (0.43, 0.54) 16.43 0.51 (0.45, 0.57) 15.64 0.59 (0.53, 0.66) 13.46
Baseline minimum
JSW [mm]
1.94 (1.19, 2.69) 4.13 1.66 (1.01, 2.32) 4.81 1.42 (0.57, 2.27) 5.63
4-year JSN [mm] 2.31 (1.18, 3.44) 3.46 2.56 (1.57, 3.54) 3.13 2.03 (0.73, 3.32) 3.95
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dictors has been summarized for 4-year KOOS Pain, Symptom, and
Qualityof Life outcomes.Withall other predictors constant, a 4.1, 4.8,
and 5.6 mm lower baseline JSW resulted in an eight-point drop in
4-year KOOS Pain, Symptom, and Quality of Life scores, respectively.
Additionally, a 3.5, 3.1, and 4.0mmdecrease in 4-year JSN resulted in
an eight-point drop in 4-year KOOS Pain, Symptom, and Quality of
Life scores, respectively.
Discussion
Our results indicate that quantitative JSW measurements are
associated with 4-year clinical outcomes in knee OA. With all other
predictors held constant, lower minimum baseline JSW and a more
negative 4-year JSN were signiﬁcantly (P < 0.01) correlated with
worse 4-year KOOS Pain, Symptom, and Quality of Life scores.
Baseline JSW and 4-year JSN did not signiﬁcantly (P < 0.01)
correlate with performance measures at the 4-year time point.
Walking pace and repeat chair stand time may not be sensitive
enough to be predicted by joint space changes. Interestingly, pa-
tients with narrower joint spaces at the onset of study had worse
KOOS Pain, Symptom, and Quality of Life scores at 4 years even after
controlling for 4-year JSN and baseline KOOS scores. These data
suggest that the joint status of the knee at the outset of the study is
as correlatedwith future clinical outcomes as the degree of JSN over
time for this cohort of patients. The 4-year KOOS Pain score was
most sensitive to changes in the baseline JSW. A 1 mm lower
baseline JSW corresponded to a 1.94 point worsening in 4-year
KOOS Pain.
Combinations of the predictors also correlated with clinically
signiﬁcant eight-point changes in the KOOS outcomemeasures. For
example, a 65-year-old white female patient with a BMI of 28, varus
alignment, baseline KOOS Pain score of 73, baseline JSWof 3.5 mm,
and 4-year JSN of 0.5 mm would be predicted to have a KOOS Pain
score of 81.4 in 4 years. In contrast, a 65-year-old white male with a
BMI of 28, valgus alignment, baseline KOOS Pain score of 73,
baseline JSWof 2.5mm, and 4-year JSN of 1mmwould be predicted
to have a KOOS Pain score of 73.1 in 4 years. This represents a
clinically signiﬁcant difference of 8.3 in the KOOS Pain score as a
result of minor changes in the patient characteristics.
Our study displays the associative value of radiographic quan-
titative JSW measurements at baseline and radiographic JSN over 4
years. Using multiple linear regression analysis, we found lower
radiographic measurements correlated with worse KOOS Pain,
Symptom, and Quality of Life outcome scores 4 years later. Previous
studies have also found a correlation between radiographic
changes and clinical symptoms16e19. A longitudinal study by Fukui
et al. concluded that worse symptoms measured via the Japanese
Knee Osteoarthritis Measure were signiﬁcantly correlated with
higher rates of JSN16. Duncan et al. reported a cross-sectional
analysis concluding that radiographic OA measured via Kellgrenand Lawrence (KL) grading correlates with pain, stiffness, and
disability measured via Western Ontario and McMaster Univer-
sities (WOMAC) Osteoarthritis Index scores17. Analyzing data from
the MOST and Framingham studies, Neogi et al. found a correlation
between knee pain and radiographic OA measured via KL grading
when comparing two knees within a person18. KL radiographic
grading was also correlated with knee pain in a within-person
comparison of the Health, Aging, and Body Composition study19.
These studies contradict the discordance between radiographic and
clinical OA found in systematic reviews9,10,20,21. Our study, in
agreement with studies ﬁnding an association, indicates a corre-
lation between radiographic and clinical OA.
KL grading, however, is not best suited for measurement of
disease progression because it is observer dependent, mixes mul-
tiple pathologic changes onto one scale, and is not linear6. By using
a continuous quantitative JSW measurement and 4-year longitu-
dinal data with a large nationwide study sample, we have shown
the correlation between baseline radiographic measurements for
progression and standardized KOOS clinical outcome measures.
The prediction of disease progression is central in a patient care
perspective. Previous studies have shown that knees with worse
initial radiographic KL grades were more likely to worsen radio-
graphically over time22,23. We have shown worse initial JSW mea-
surements lead toworse clinical outcomes over time after adjusting
for multiple confounding variables. Baseline JSW remains inde-
pendently correlated with worse KOOS outcome scores even after
4-year JSN and baseline KOOS scores were adjusted for in the
multiple linear regression. These results suggest that once the
disease process has begun the clinical outcome is predetermined to
an extent. Therefore, it may be necessary to begin disease modi-
fying OA therapies in an early stage of disease. As baseline JSW is
independently associated with 4-year clinical outcomes, it could be
used as an early surrogate marker for the effectiveness and beneﬁt
of prior disease modifying therapy over a longer time course.
Radiographic JSW changes may manifest before clinically impor-
tant outcomes in knee OA. Future studies looking at the impact of
early JSW changes (e.g., loss over 1e2 years) on the progression of
OA signs and symptoms could provide a means of targeting
potentially vulnerable patient populations early on. Treating these
patients with disease modifying agents and measuring clinical
outcomes could show slowing, stabilizing, or even reversal of dis-
ease progression over time.
There are several limitations in this study. The study population
included only individuals with symptomatic and radiographic OA at
the onset. Future studies should assess the predictive value of
structural JSW measures in patients with earlier OA and asymp-
tomatic patients who progress to symptomatic OA. The right knee
was chosen in all patients to avoid subjectively choosing KL grade
or KOOS Pain score to judge which knee was most diseased when a
large proportion of patients’ knees could not be differentiated in
this way. Only one knee per patient was used for analysis to avoid
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regression analysis however, the right knee may not have been the
most symptomatic knee in each patient. Attempting to correlate
radiographic data of an individual knee with global patient
outcome data may have decreased the correlation between JSW
and select outcomes. While outcome measures for KOOS Pain and
Symptoms were reported uniquely for each knee, KOOS Quality of
Life, KOOS Function, Sports, and Recreation, and performance
measures were reported for the patient not each knee. Additionally,
there is the possibility that patients were able to perform the 20-
m walk and chair stands at a higher level than typical for a brief
period of time despite negative joint changes. These factors could
explain why a statistically signiﬁcant correlation was not found for
KOOS Function, Sports, and Recreation scores and performance
measures. A systematic review by Dobson et al. concluded the
timed up and go test and multi-activity measures like the Stratford
battery, the Physical Activity Restrictions, and Functional Assess-
ment System were part of the best rated performance measures in
lower limb OA24. These performance measures could be more
sensitive to changes in JSW and warrant future evaluation.
Our study included minimum JSW measurements of either the
medial or lateral compartments of the knee to assess narrowing
throughout the knee joint. Analysis of the data using only medial
compartments yielded similar results (data not shown). Analysis of
ﬁxed location JSW in the medial compartment was also conducted
by comparing the lowest ﬁxed location JSW at baseline with the
same location after 4 years. The analysis yielded similar results for
all of themodels except for the KOOS Quality of Life model: baseline
JSW (P ¼ 0.031) and 4-year JSN (P ¼ 0.023) were no longer statis-
tically signiﬁcant predictors (P < 0.01) of 4-year KOOS Quality of
Life scores (data not shown). Fixed location JSW showed less
change over time compared to minimum JSW.
In conclusion, our results indicate that quantitative joint space
measurements are signiﬁcantly correlated with 4-year clinical out-
comes in knee OA. The results show that a lower initial JSW and a
larger 4-yeardecrease in JSWareboth independentlyassociatedwith
worse KOOS Pain, Symptom, and Quality of Life scores after 4 years.
The strong association is one feature in knee OA supporting a caus-
ative role between structural OA and clinical outcomes. As patients
with narrower JSWat the onset of study hadworse clinical outcomes
after4 years, any therapeutic interventionwouldbemostbeneﬁcial if
treatment is targeted as early as possible in the disease process.
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